Ferreira do Couto Maria Leonor, Fonseca Sara, Pozza Daniel Humberto
Experimental Biology Unit, Department of Biomedicine, Faculty of Medicine of Porto, University of Porto, 4200-319 Porto, Portugal.
Anesthesiology Department, São João University Hospital Centre, 4200-135 Porto, Portugal.
Biomedicines. 2024 Mar 25;12(4):729. doi: 10.3390/biomedicines12040729.
Despite technical and pharmacological advancements in recent years, including optimized therapies and personalized medicine, postoperative pain management remains challenging and sometimes undertreated. This review aims to summarize and update how genotype-guided therapeutics within personalized medicine can enhance postoperative pain management. Several studies in the area have demonstrated that genotype-guided therapy has the ability to lower opioid consumption and improve postoperative pain. Gene mutations, primarily , , , and , have been shown to exert nuanced influences on analgesic response and related pharmacological outcomes. This review underscores the integration of pharmacogenetic-guided personalized medicine into perioperative care, particularly when there is uncertainty regarding opioid prescriptions. This approach leads to superior outcomes in terms of postoperative pain relief and reduced morbidity for numerous patients.
尽管近年来在技术和药理学方面取得了进展,包括优化治疗和个性化医疗,但术后疼痛管理仍然具有挑战性,有时治疗不足。本综述旨在总结和更新个性化医疗中基因分型指导的治疗方法如何改善术后疼痛管理。该领域的多项研究表明,基因分型指导的治疗方法能够减少阿片类药物的使用并改善术后疼痛。已证明基因突变,主要是 、 、 、 和 ,对镇痛反应和相关药理学结果有细微影响。本综述强调将药物遗传学指导的个性化医疗纳入围手术期护理,特别是在阿片类药物处方存在不确定性时。这种方法在术后疼痛缓解和降低众多患者的发病率方面产生了更好的效果。